The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InIn a move reflecting a masterclass in corporate restructuring, CEO Larry Culp has successfully navigated GE through a complex turnaround since taking the helm. According to analyst reports, Culp effectively reduced the company's crushing debt load and orchestrated a strategic split into three independent, profitable public entities: GE HealthCare, GE Vernova, and GE Aerospace. This transformation utilized a 'lean' manufacturing philosophy to stabilize the firm and prevent a total collapse.
Examining the performance of the resulting entities per market data, GE Aerospace (GE) closed at $341.19 as of July 22, 2026. Meanwhile, GE HealthCare (GEHC) stood at $62.83 at the close of July 20, 2026, and GE Vernova (GEV) reached a level of $1078.81 as of July 21, 2026. These figures highlight the market valuation established following the final separation of the power and aerospace franchises in early 2024.
Investors should watch for continued operational efficiency, noting that GE shares traded between a low of $340.37 and a high of $345.2 in its most recent session. While the upcoming economic calendar shows no direct corporate catalysts, broader industrial health remains relevant, as evidenced by the Philadelphia Fed Manufacturing Index which recently posted a significant reading of 41.4, far exceeding forecasts.